Table 2.
Included trials | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other sources of bias | Risk of bias |
---|---|---|---|---|---|---|---|---|
Liu et al., 2009 [30] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Chen et al., 2006 [31] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Ji and Han, 2011 [32] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Yuan, 2006 [33] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Shi, 2011 [34] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
Li and Wan, 2006 [35] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Liang, 2011 [36] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Fu and Xiao, 2011 [37] | Table of random number | Unclear | Unclear | Unclear | Yes | Yes | Unclear | Unclear |
Yang et al., 2008 [38] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |
Lin and Zhou, 2004 [39] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
Ai, 2012 [40] | Unclear | Unclear | Unclear | Unclear | Yes | Yes | Unclear | High |
Qin, 2008 [41] | Unclear | Unclear | Unclear | Unclear | Yes | No | Unclear | High |